News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
259,362 Results
Type
Article (13833)
Company Profile (293)
Press Release (245236)
Section
Business (79306)
Career Advice (147)
Deals (13176)
Drug Delivery (31)
Drug Development (50265)
Employer Resources (31)
FDA (5668)
Job Trends (5110)
News (144023)
Policy (10013)
Tag
Academia (901)
Alliances (21441)
Alzheimer's disease (731)
Approvals (5632)
Artificial intelligence (61)
Bankruptcy (97)
Best Places to Work (4476)
Biotechnology (241)
Breast cancer (59)
Cancer (620)
Cardiovascular disease (52)
Career advice (128)
CAR-T (48)
Cell therapy (157)
Clinical research (39642)
Collaboration (207)
Compensation (86)
COVID-19 (999)
C-suite (60)
Cystic fibrosis (61)
Data (668)
Diabetes (66)
Diagnostics (1195)
Earnings (28760)
Events (46642)
Executive appointments (157)
FDA (5921)
Funding (213)
Gene editing (52)
Gene therapy (130)
GLP-1 (295)
Government (1063)
Healthcare (6528)
Infectious disease (1030)
Inflammatory bowel disease (89)
IPO (7170)
Job creations (859)
Job search strategy (124)
Layoffs (182)
Legal (1372)
Lung cancer (104)
Manufacturing (68)
Medical device (2548)
Medtech (2549)
Mergers & acquisitions (6092)
Metabolic disorders (209)
Neuroscience (913)
NextGen Class of 2024 (1997)
Non-profit (842)
Northern California (835)
Obesity (120)
Opinion (90)
Parkinson's disease (55)
Patents (47)
People (24905)
Pharmaceutical (48)
Phase I (13945)
Phase II (18431)
Phase III (11694)
Pipeline (216)
Postmarket research (846)
Preclinical (5891)
Radiopharmaceuticals (203)
Rare diseases (145)
Real estate (1409)
Regulatory (8171)
Research institute (930)
Southern California (774)
Startups (1963)
United States (6927)
Vaccines (156)
Weight loss (75)
Date
Today (148)
Last 7 days (628)
Last 30 days (1977)
Last 365 days (20547)
2024 (18090)
2023 (22412)
2022 (26823)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16778)
Australia (2821)
California (1894)
Canada (662)
China (142)
Colorado (70)
Connecticut (75)
Europe (36117)
Florida (200)
Georgia (55)
Illinois (118)
Indiana (53)
Kansas (55)
Maryland (280)
Massachusetts (1567)
Michigan (46)
Minnesota (85)
New Jersey (505)
New York (562)
North Carolina (385)
Northern California (835)
Ohio (73)
Pennsylvania (390)
South America (207)
Southern California (774)
Texas (194)
Washington State (203)
259,362 Results for "kymera therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
November 5, 2024
·
1 min read
Genetown
Kymera Therapeutics to Participate in Upcoming June 2024 Investor Conferences
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation, announced that the Company will participate in fireside chats at the following upcoming investor events.
May 29, 2024
·
1 min read
Press Releases
Kymera Therapeutics to Report Third Quarter 2024 Financial Results on October 31
October 24, 2024
·
1 min read
Press Releases
Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
October 31, 2024
·
14 min read
Genetown
Kymera Therapeutics to Participate in Upcoming May Investor Conferences
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation, announced that the Company will participate in fireside chats at the following upcoming investor events.
May 8, 2024
·
1 min read
Press Releases
Kymera Therapeutics Announces Three Scientific Presentations at the EORTC-NCI-AACR 2024 Symposium
October 24, 2024
·
5 min read
Business
Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2
Kymera Therapeutics, Inc. will report first quarter 2024 financial results on May 2, 2024, and will host a conference call at 8:30 a.m. ET.
April 25, 2024
·
1 min read
Business
Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
Kymera Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2024, and provided business highlights and updates on its pipeline of protein degraders.
May 2, 2024
·
13 min read
Press Releases
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
August 28, 2024
·
1 min read
Drug Development
Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation, shared new clinical data from its ongoing KT-333 Phase 1 trial.
June 14, 2024
·
9 min read
1 of 25,937
Next
